Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$24.31 - $33.6 $243 - $336
-10 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$33.06 - $56.93 $330 - $569
10 New
10 $0

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Berkshire Capital Holdings Inc Portfolio

Follow Berkshire Capital Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Capital Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Capital Holdings Inc with notifications on news.